Search Results 2301-2310 of 20223 for Receptor

  1. Neurology - Clinical trials - Mayo Clinic

    Memantine hydrochloride may enhance cognitive function by binding to and inhibiting channels of receptors located in the central nervous system. Radiation ...

  2. Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors - Mayo Clinic

    receptor. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 1/30/24. Questions regarding updates should be ...

  3. Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer - Mayo Clinic

    H-2 receptor antagonists and antacids are allowed - Patients who cannot discontinue drugs that are strong inhibitors of CYP3A4 or CYP1A2 - Patients who ...

  4. Pediatric metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD) - Mayo Clinic

    ... receptor gene or congenital leptin deficiency). These conditions have specific treatments and are important to identify early in life. "However, a larger ...

  5. Ramucirumab (intravenous route) - Side effects & uses - Mayo Clinic

    ... receptor (EGFR) gene (exon 19 deletions or exon 21 mutations). Your doctor will perform a test before you take this medicine. Ramucirumab injection is also ...

  6. Movement disorders - Doctors and departments - Mayo Clinic

    Andrew McKeon, M.B., B.Ch., M.D.. Neurologist. Rochester, MN. Areas of focus: Movement disorder, Dystonia, NMDA receptor antibody encephalitis, Myelin ...

  7. Movement disorders - Doctors and departments - Mayo Clinic

    Andrew McKeon, M.B., B.Ch., M.D.. Neurologist. Rochester, MN. Areas of focus: Movement disorder, Dystonia, NMDA receptor antibody encephalitis, Myelin ...

  8. Neurology - Doctors - Mayo Clinic

    ... receptor antibody encephalitis, Primary progressive aphasia, Posterior cortical atrophy, Autoimmune encephalitis, Wernicke-Korsakoff syndrome. Show more ...

  9. Neurology - Doctors - Mayo Clinic

    ... receptor antibody encephalitis, Primary progressive aphasia, Posterior cortical atrophy, Autoimmune encephalitis, Wernicke-Korsakoff syndrome. Show more ...

  10. A Study of V940 Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002) - Mayo Clinic

    ... receptor. * Received prior systemic anticancer therapy including investigational agents within 4 weeks before randomization. * Received a live or live ...